- Home
- OCS vs WLKP Comparison
OCS vs WLKP Comparison
Compare OCS & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OCS | WLKP |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 732.4M | 762.4M |
| IPO Year | 2022 | 2014 |
Fundamental Metrics
Financial Performance| Metric | OCS | WLKP |
|---|---|---|
| Price | $10.07 | $21.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $42.00 | N/A |
| AVG Volume (30 Days) | ★ 142.9K | 20.4K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 8.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,166,695,000.00 |
| Revenue This Year | $466.06 | $19.48 |
| Revenue Next Year | $479.73 | $5.24 |
| P/E Ratio | ★ N/A | $15.30 |
| Revenue Growth | N/A | ★ 2.71 |
| 52 Week Low | $10.50 | $17.75 |
| 52 Week High | $34.48 | $23.88 |
Technical Indicators
Market Signals| Indicator | OCS | WLKP |
|---|---|---|
| Relative Strength Index (RSI) | 24.29 | 42.67 |
| Support Level | N/A | $21.45 |
| Resistance Level | $13.49 | $22.27 |
| Average True Range (ATR) | 0.53 | 0.38 |
| MACD | -0.21 | -0.02 |
| Stochastic Oscillator | 3.42 | 17.17 |
Price Performance
Historical ComparisonAbout OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
About WLKP Westlake Chemical Partners LP
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen, to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.